Lung Biopsy Systems Market Size

Lung Biopsy Systems Market size was valued at USD 3.46 Billion in 2023 and is set to reach USD 22.28 Billion by the end of 2036, expanding at around 15.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of lung biopsy systems is assessed at USD 3.94 Billion. The reason behind the growth is impelled by a higher prevalence of lung cancer across the globe. As a result, there is a greater need for timely diagnosis which necessitates the use of a lung biopsy system. By extracting samples of lung tissue that may be utilized for molecular testing, a lung biopsy is a generally acknowledged method for identifying pulmonary illnesses. A report published by World Health Organization (WHO) stated that in 2020, around 10 million people died due to lung cancer which was summed up to be 1 in 6 deaths worldwide.

The growing inclination toward minimally invasive surgeries is believed to fuel lung biopsy systems market growth. Minimally invasive surgeries come under the ongoing advancement of the medtech industry and it is performed by delivering less damage to the body with the assistance of enhanced medical imaging equipment services.

Moreover, the use of a robotic-assisted system in minimally invasive lung biopsy enables medical professionals performing the procedure to access all 18 lung regions, enabling the best lung navigation and producing more precise biopsies. This type of treatment is safe, effective, and minimally invasive, which can reduce discomfort, recovery time, and infection risk.